Patient-reported functioning in major depressive disorder
Open accessThe DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
Objectives: Compared with the general population, patients with major depressive disorder (MDD) report substantial deficits in their functioning that often go beyond the clinical resolution of depressive symptoms. This study examines the impact of MDD and its treatment on functioning. Methods: From the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial, we analyzed complete data of 2280 adult outpatients with MDD at entry and exit points of each level of antidepressant treatment and again 12 months post treatment. Functioning was measured using the Work and Social Adjustment Scale (WSAS). Results: The results show that only 7% of patients with MDD reported within-normal functioning before treatment. The proportion of patients achieving within-normal functioning (WSAS) scores significantly increased after treatment. However, the majority of patients (>60%) were still in the abnormal range on functioning at exit. Although remitted patients had greater improvements compared with nonremitters, a moderate proportion of remitted patients continued to experience ongoing deficits in functioning after treatment (20–40%). Follow-up data show that the proportions of patients experiencing normal scores for functioning after 12 months significantly decreased from the end of treatment to the follow-up phase, from 60.1% to 49% ( p < 0.0001), a finding that was particularly significant in nonremitters. Limitations of this study include the reliance on self-report of functioning and the lack of information on patients who dropped out. Conclusion: This study points to the importance of functional outcomes of MDD treatment as well as the need to develop personalized interventions to improve functioning in MDD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Further drawbacks of existing TRD defi nitions are that they fail to take into consid eration the social, economic, anamnestic (e.g., adverse childhood experiences) and interpersonal factors which, alone or in combinations, are known to moderate antidepressant response 1,44,47,71,75- 81 .”
From Treatment‐resistant depression: definition, prevalence, detection, management, and investigational interventions (2023) · cites this paper as [77]
Citations
Cites
Statistical Power Analysis for the Behavioral Sciences
Muller, K. (1989) · Technometrics · doi:10.1080/00401706.1989.10488618 · Cited by 99,167
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., Niederehe, G., Thase, M. E., Lavori, P. W., Lebowitz, B. D., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.11.1905 · Cited by 5,643
Rush, A. J., Trivedi, M. H., Ibrahim, H. M., Carmody, T. J., Arnow, B., Klein, D. N., Markowitz, J. C., Ninan, P. T., Kornstein, S., Manber, R., et al. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01866-8 · Cited by 3,829
The Work and Social Adjustment Scale: a simple measure of impairment in functioning
Mundt, J. C., Marks, I. M., Shear, M. K., & Greist, J. M. (2002) · British Journal of Psychiatry · doi:10.1192/bjp.180.5.461 · Cited by 2,515
Sequenced treatment alternatives to relieve depression (STAR*D): Rationale and design
Rush, A. J., Fava, M., Wisniewski, S. R., Lavori, P. W., Trivedi, M. H., Sackeim, H. A., Thase, M. E., Nierenberg, A. A., Quitkin, F. M., Kashner, T. M., et al. (2004) · Controlled Clinical Trials · doi:10.1016/s0197-2456(03)00112-0 · Cited by 1,076
Size of Treatment Effects and Their Importance to Clinical Research and Practice
Kraemer, H. C., & Kupfer, D. J. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.09.014 · Cited by 850 · cited 2×
“Clinical significance for numerical outcomes was estimated using effect sizes [Kraemer, 2006] in which Cohen’s d values of 0.2, 0.5 and 0.8 describe small, medium and large effects, respectively [Cohen, 1988].”
MethodInfluentialHays, R. D. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950130011002 · Cited by 841 · cited 1×
“Some studies even documented that the severity of functional impairments associated with depression are comparable to or even worse than those associated with other major medical problems [Hays et al. 1995].”
ResultAalbers, S., Fusar-Poli, L., Freeman, R. E., Spreen, M., Ket, J. C., Vink, A. C., Maratos, A., Crawford, M., Chen, X.-J., & Gold, C. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004517.pub3 · Cited by 838
Judd, L. L., Akiskal, H. S., Maser, J. D., Zeller, P. J., Endicott, J., Coryell, W., Paulus, M. P., Kunovac, J. L., Leon, A. C., Mueller, T. I., et al. (1998) · Journal of Affective Disorders · doi:10.1016/s0165-0327(98)00138-4 · Cited by 590
Nyklíček, I., & Kuijpers, K. F. (2008) · Annals of Behavioral Medicine · doi:10.1007/s12160-008-9030-2 · Cited by 532 · cited 2×
“2005], meditation [Nyklicek and Kuijpers, 2008], massage [Hamre et al.”
Research works printed but not linked: 6
- Dubini A., 1997, J Psychopharmacol, 11, S17
- Kennedy S., 2002, J Psychiatry Neurosci, 27, 233
- Kongsakon R., 2005, J Med Assoc Thai, 88, 1261
- Maratos A., 2008, Cochrane Database Syst Rev, CD004517
- Romera I., 2013, Actas Esp Psiquiatr, 41, 263
- Strean W., 2009, Can Fam Physician, 55, 965
Cited by
McIntyre, R. S., Alsuwaidan, M., Baune, B. T., Berk, M., Demyttenaere, K., Goldberg, J. F., Gorwood, P., Ho, R., Kasper, S., Kennedy, S. H., et al. (2023) · World Psychiatry · doi:10.1002/wps.21120 · Cited by 836
Cognitive dysfunction in major depressive disorder
Knight, M. J., & Baune, B. T. (2018) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000378 · Cited by 207
Functional and cognitive impairment in the first episode of depression: A systematic review
Varghese, S., Frey, B. N., Schneider, M. A., Kapczinski, F. P., & Cardoso, T. D. A. (2021) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13385 · Cited by 150
Functional impairment in patients with major depressive disorder: the 2-year PERFORM study
Hammer-Helmich, L., Haro, J. M., Jönsson, B., Melac, A. T., di Nicola, S., Chollet, J., Milea, D., Rive, B., & Saragoussi, D. (2018) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s146098 · Cited by 161
van Dijk, D. A., Meijer, R. M., van den Boogaard, T. M., Spijker, J., Ruhé, H. G., & Peeters, F. P. M. L. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.11.011 · Cited by 76
Cha, D. S., Carmona, N. E., Subramaniapillai, M., Mansur, R. B., Lee, Y. L., Lee, J. H., Lee, J., Rosenblat, J. D., Shekotikhina, M., Park, C., et al. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.06.036 · Cited by 64
Chokka, P. R., Bougie, J. K., Proulx, J., Tvistholm, A. H., & Ettrup, A. (2019) · CNS Spectrums · doi:10.1017/s1092852919000786 · Cited by 57
Emotional blunting in patients with depression. Part I: clinical characteristics
Christensen, M. C., Ren, H., & Fagiolini, A. (2022) · Annals of General Psychiatry · doi:10.1186/s12991-022-00387-1 · Cited by 53
Kan, K., Jörg, F., Buskens, E., Schoevers, R. A., & Alma, M. (2020) · BJPsych Open · doi:10.1192/bjo.2020.27 · Cited by 45
Mattingly, G. W., Ren, H., Christensen, M. C., Katzman, M. A., Polosan, M., Simonsen, K., & Hammer-Helmich, L. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.824831 · Cited by 47
The impact of major depressive disorder on adaptive function: A retrospective observational study
Park, E., & Jung, M. H. (2019) · Medicine · doi:10.1097/md.0000000000018515 · Cited by 44
“This study replicated the existing evidence([22,23]) by showing significant differences between global and domain-specific functional outcomes in patients with MDD and a general healthy population.”
Habtamu, K., Medhin, G., Selamu, M., Tirfessa, K., Hanlon, C., & Fekadu, A. (2019) · International Journal of Mental Health Systems · doi:10.1186/s13033-019-0305-8 · Cited by 38
Liang, S., Xue, K., Wang, W., Yu, W., Ma, X., Luo, S., Zhang, J., Sun, X., Luο, X., Liu, F., et al. (2020) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2020.111134 · Cited by 39
Sumiyoshi, T., Watanabe, K., Noto, S., Sakamoto, S., Moriguchi, Y., Hammer-Helmich, L., & Fernandez, J. L. (2021) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s288108 · Cited by 32
“Deficits in patient-reported functioning may also persist after resolution of depressive symptoms.(10) Thus, there is growing”
Haro, J. M., Hammer-Helmich, L., Saragoussi, D., Ettrup, A., & Larsen, K. G. (2019) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s206825 · Cited by 29
“In a large US study designed to assess the efficacy of sequential acute treatments for MDD (Sequenced Treatment Alternatives to Relieve Depression [STAR*D]), only 7% of patients reported within-normal functioning before initiation of antidepressant therapy.(6) In STAR*D, patients who achieved remission of depressive s…”
BackgroundBaune, B. T., Florea, I., Ebert, B., Touya, M., Ettrup, A., Hadi, M., & Ren, H. (2021) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s325954 · Cited by 24
Sex differences in the mediators of functional disability in Major Depressive Disorder
Carmona, N. E., Subramaniapillai, M., Mansur, R. B., Cha, D. S., Lee, Y., Fus, D., & McIntyre, R. S. (2018) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2017.09.025 · Cited by 22
The Increasing Economic Burden with Additional Steps of Pharmacotherapy in Major Depressive Disorder
Arnaud, A. M., Suthoff, E. D., Tavares, R. M., Zhang, X., & Ravindranath, A. J. (2021) · PharmacoEconomics · doi:10.1007/s40273-021-01021-w · Cited by 21
Chokka, P. R., Tvistholm, A. H., Bougie, J. K., Clerzius, G., & Ettrup, A. (2020) · Journal of Occupational and Environmental Medicine · doi:10.1097/jom.0000000000001805 · Cited by 20
“However, impairments in workplace functioning and productivity have been shown to persist in patients with MDD even after remission of mood symptoms.(62,63) Cognitive symptoms have also been shown to persist longer than depressive symptoms in patients with MDD and can persist even in patients who achieve remission of…”
BackgroundGuilera, G., Gómez‐Benito, J., Vieta, E., Rojo, E., Barrios, M., & Pino, Ó. (2020) · Psicothema · doi:10.7334/psicothema2019.186 · Cited by 24
“Moreover, it is known that this functional disability persists during relatively symptom-free periods (IsHak et al., 2016; Karow, Moritz, Lambert, Schöttle, & Naber, 2012; Samalin et al., 2017).”
BackgroundChristensen, M. C., Ren, H., & Fagiolini, A. M. (2022) · Annals of General Psychiatry · doi:10.1186/s12991-022-00392-4 · Cited by 21
“Depression is associated with a wide range of emotional, physical, and cognitive symptoms that have a significant impact on patients’ functioning and health-related quality of life [2, 4, 5].”
BackgroundAyyagari, R., Thomason, D., Mu, F., Philbin, M. J., & Carroll, B. (2019) · Journal of Medical Economics · doi:10.1080/13696998.2019.1685818 · Cited by 20
Lee, M., Choi, H. N., Shin, J., & Suh, H.-S. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20010091 · Cited by 44
“The functional decrement attributable to depression can last even after depressive symptoms are remarkably improved [10]; it is a lasting and debilitating outcome that leads to substantial personal, familial, and social burdens.”
BackgroundIn pursuit of full recovery in major depressive disorder
Vicent-Gil, M., Serra-Blasco, M., Navarra‐Ventura, G., Trujols, J., Balanzá‐Martínez, V., Portella, M. J., & Cardoner, N. (2022) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-022-01487-5 · Cited by 15
“The present findings confirm the notion that clinical remission (as rated by the healthcare professional) from a depressive episode does not equate to functional remission [1].”
BackgroundResultRelationship between cognitive function and functional outcomes in remitted major depression
Luo, R., Fan, N., Dou, Y., Wang, Y., Wang, M., Yang, X., & Ma, X. (2024) · BMC Psychiatry · doi:10.1186/s12888-024-05675-6 · Cited by 16
“This finding aligns with limited studies on long-term functional outcomes in MDD [12, 33], which have indicated that a significant number of MDD patients still suffered from social dysfunction even in clinical remission.”
BackgroundResultRandomized clinical trial of integral cognitive remediation program for major depression (INCREM)
Vicent-Gil, M., González-Simarro, S., Raventós, B., Vera, J., Martínez, E. D. M., Sabaté-Cao, C., Pérez‐Blanco, J., Puigdemont, D., de Diego-Adeliño, J., Alemany, C., et al. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.05.016 · Cited by 15
Papalexi, E., Galanopoulos, A., Kontis, D., Markopoulou, M., Balta, G., Karavelas, E., Panagiotidis, P., Vlachos, T., & Ettrup, A. (2022) · BMC Psychiatry · doi:10.1186/s12888-022-04109-5 · Cited by 16
“Functional recovery is the current treatment goal for patients with MDD [3–6]; however, functional impairment may persist even after resolution of other symptoms [7].”
BackgroundIsHak, W. W., Steiner, A. J., Klimowicz, A., Kauzor, K. E., Dang, J., Vanle, B., Elzahaby, C., Reid, M. W., Sumner, L. A., & Danovitch, I. (2025) · Psychopharmacology Bulletin · doi:10.64719/pb.4558 · Cited by 20
Self-citationFilippis, S. D., Pugliese, A., Christensen, M. C., Rosso, G., Nicola, M. D., Simonsen, K., & Ren, H. (2022) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s375294 · Cited by 13
“Major depressive disorder (MDD) is a multidimensional condition characterized by a range of emotional, cognitive, and physical symptoms that have a significant impact on psychosocial functioning.(7,8) According to the Canadian Network for Mood and Anxiety Treatments (CANMAT) treatment guidelines issued in 2016, restor…”
BackgroundIliou, K., Balaris, D., Dokali, A. M., Fotopoulos, V., Kouletsos, A., & Katsiana, A. (2024) · Cureus · doi:10.7759/cureus.55831 · Cited by 17
“Nevertheless, numerous studies have demonstrated that factors beyond the mere remission of a depressive episode can directly impact functioning, including the combination of pharmacotherapy with psychotherapy [38,39].”
BackgroundIsHak, W. W., Mirocha, J., Dang, J., Vanle, B., Metrikin, B., Tessema, K. K., Steiner, A. J., & Danovitch, I. (2024) · Psychiatric Research and Clinical Practice · doi:10.1176/appi.prcp.20230064 · Cited by 18
“� Treatment efforts should focus not only on symptom remission, but also on restoring QOL and functioning in psychiatric patients, particularly among those with mood disorders. patients (11).”
Self-citationThe pattern glare and visual memory are disrupted in patients with major depressive disorder
Wang, M., Qi, X., Yang, X., Fan, H., Dou, Y., Guo, W., Wang, Q., Chen, E. Y. H., Li, T., & Ma, X. (2022) · BMC Psychiatry · doi:10.1186/s12888-022-04167-9 · Cited by 12
“Moreover, memory deficits during acute and remitted stages of MDD can contribute to symptoms of low mood and reduced occupational and social functioning that have clinical importance [11, 12].”
BackgroundChristensen, M. C., Cañellas, F., Loft, H., & Montejo, A. L. (2024) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s473056 · Cited by 11
The United States index of socioeconomic deprivation for individuals (USiDep)
Dunlop, B. W., Rakofsky, J. J., Mischoulon, D., Mayberg, H. S., Kinkead, B. L., Nierenberg, A. A., Ziegler, T. R., D, M. F. M., & Rapaport, M. H. (2022) · Personalized Medicine in Psychiatry · doi:10.1016/j.pmip.2022.100091 · Cited by 11
Development of a psychosocial functioning questionnaire for patients with major depressive disorder
Zhang, X. J., Yang, H., Ma, H., Teng, C., Wang, H., Diao, K., & Zhang, N. (2022) · General Psychiatry · doi:10.1136/gpsych-2021-100527 · Cited by 9
McIntyre, R. S., Maletic, V., Masand, P. S., Wilson, A. C., Yu, J., Adams, J. L., & Kerolous, M. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.05.026 · Cited by 13
Nicola, M. D., Adair, M., Rieckmann, A., & Cronquist Christensen, M. (2024) · Journal of Psychopharmacology · doi:10.1177/02698811241260996 · Cited by 9
“Major depressive disorder (MDD) is marked by significant impairments in psychosocial functioning, which can persist despite improvements in disease severity (IsHak et al., 2016).”
BackgroundChristensen, M. C., Schmidt, S. N., & Grande, I. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.07.018 · Cited by 6
Redefining Therapeutic Outcomes of Depression Treatment
Slofstra, C., Booij, S. H., Hoenders, R. H. J., & Castelein, S. (2019) · Journal for Person-Oriented Research · doi:10.17505/jpor.2019.10 · Cited by 10
“…remission, patients often experience impairments in diverse forms of functioning (de Vries, Koeter, Nieuwenhuijsen, Hees, & Schene, 2015; IsHak et al., 2016; Lerner & Henke, 2008; McKnight & Kashdan, 2009; Sarfati et al., 2017; Trivedi et al., 2013) and quality of life (IsHak et al.,…”
BackgroundSchaich, A., Outzen, J., Assmann, N., Gebauer, C., Jauch‐Chara, K., Alvarez‐Fischer, D., Hüppe, M., Wells, A., Schweiger, U., Klein, J. P., et al. (2022) · Psychotherapy and Psychosomatics · doi:10.1159/000527482 · Cited by 8
Evolution of sexual functioning of men through treated and untreated depression
Laforgue, E., Busnel, G., Lauzeille, D., Grall‐Bronnec, M., Cabelguen, C., Bulteau, S., Vanelle, J., Jolliet, P., Sauvaget, A., & Victorri‐Vigneau, C. (2021) · L Encéphale · doi:10.1016/j.encep.2021.06.008 · Cited by 8
Christensen, M. C., Grande, I., Rieckmann, A., & Chokka, P. R. (2024) · CNS Spectrums · doi:10.1017/s1092852924000610 · Cited by 6
Almeida, S. S., Christensen, M. C., Simonsen, K., & Adair, M. (2022) · Journal of Psychopharmacology · doi:10.1177/02698811221132468 · Cited by 6
“…disorder (MDD) is characterized by a heterogeneous range of emotional, cognitive and physical impairments (Fried and Nesse, 2014; Goodwin et al., 2017; IsHak et al., 2016), and is a leading cause of disability worldwide (GBD 2017 Disease and Injury Incidence and Prevalence Collaborators, 2018).”
BackgroundInfluentialPolosan, M., Rabbani, M., Christensen, M. C., Simonsen, K., & Ren, H. (2022) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s374635 · Cited by 6
“MDD is a heterogeneous condition associated with a spectrum of emotional, cognitive, and physical symptoms that impact significantly on psychosocial functioning.(3,4) Functional impairment contributes significantly to the social and economic burden of MDD.”
BackgroundAlmarghalani, D. A., Al-Otaibi, K. M., Labban, S. Y., Fathelrahman, A. I., Alzahrani, N. A., Aljuhaiman, R., & Jamous, Y. F. (2025) · Healthcare · doi:10.3390/healthcare13151854 · Cited by 8
“The duality of feeling improved versus impaired is a common issue, with benefits often weighed against side effects [41,42].”
Wang, G., Si, T., Rieckmann, A., Ma, J., & Christensen, M. C. (2024) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s460408 · Cited by 5
“30,32,33 This is of clinical significance, as residual functional impairment has been shown to predict subsequent relapse.”
BackgroundSkelton, M., Mundy, J., ter Kuile, A., Adey, B. N., Armour, C., Buckman, J. E. J., Coleman, J. R. I., Davies, M. R., Hirsch, C. R., Hotopf, M. H., et al. (2025) · Psychological Medicine · doi:10.1017/s0033291725101037 · Cited by 6
“Furthermore, some patients considered to be in remission report persistent impairment from residual symptoms (IsHak et al., 2016; Saris et al., 2017).”
Raveendran, S., Singh, D., Burke, M. C., McAuliffe‐Fogarty, A. H., Parikh, S. V., McIntyre, R. S., Roy, A., Martin, M., Chrones, L., Opler, M. G. A., et al. (2023) · BMC Psychiatry · doi:10.1186/s12888-023-04922-6 · Cited by 3
“Symptoms of MDD, such as the inability to maintain relationships and engage in leisure activities, are disabling for the patient, significantly impairing their daily life and functioning [7].”
BackgroundPrivate Office, S., Kartal, C., & Aydın, E. F. (2023) · Psychiatry and Clinical Psychopharmacology · doi:10.5152/pcp.2023.22597 · Cited by 6
Alcalá, J. Á., Dorado, V. O., Herrera, G. D. P. A., Chamón, S. L., & Molinera, V. G. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1568777 · Cited by 2
Determining the cognitive performance in the first episode of depression
Vicent-Gil, M., & Portella, M. J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-817935-2.00007-6 · Cited by 2
Psychosocial functionality in depressive workers: A study on associated factors
Prado, J. D. A., & Santos, J. L. F. (2021) · International Journal of Social Psychiatry · doi:10.1177/00207640211011195 · Cited by 4
Wedema, D., Hovenkamp-Hermelink, J., Korevaar, E. L., Wardenaar, K. J., & Schoevers, R. A. (2025) · Psychotherapy and Psychosomatics · doi:10.1159/000548808 · Cited by 3
“While treatment often alleviates symptoms, its impact on overall functioning seems limited [6, 7], with many individuals experiencing persistent functional impairments or a rapid decline in functioning after treatment [8].”
Pathogenetic mechanisms of antinociceptive activity of antidepressants
Scheidegger, J. M., DOROVSKIKH, I. V., & Pavlova, T. A. (2020) · Pharmacy Formulas · doi:10.17816/phf34802 · Cited by 1
Liu, D., & He, W. (2024) · Statistics in Biosciences · doi:10.1007/s12561-024-09471-4 · Cited by 1
“The importance of developing individualized treatments for patients with major depressive disorder was emphsized to improve their long-term functioning [17].”
Evaluation of Male Hypoactive Sexual Desire Disorder
Pizano, D. R., & Ishak, W. (2017) · Springer eBooks · doi:10.1007/978-3-319-52539-6_8 · Cited by 1
Self-citationBaek, J. H. (2022) · Psychiatric Annals · doi:10.3928/00485713-20220217-01 · Cited by 1
Costas‐Carrera, A., Garrido, G., Penadés, R., Jovell, E., Valenzuela, L., Vendrell, J. M., & Ramos-Grille, I. (2020) · Psiquiatría Biológica · doi:10.1016/j.psiq.2020.08.003 · Cited by 1
The effectiveness of vortioxetine in patients with depression in real clinical practice
Петрова, Н. Н. (2022) · V M BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY · doi:10.31363/2313-7053-2022-56-3-113-118
Skelton, M., Catarino, A., Brown, S. A. T., Carr, E., Davies, M. R., Peel, A. J., Rayner, C., Breen, G. D., & Eley, T. C. (2023) · Behaviour Research and Therapy · doi:10.1016/j.brat.2023.104386 · Cited by 1
The genetic overlap between functional impairment and severity of depression and anxiety symptomsPreprint
Skelton, M., Mundy, J., ter Kuile, A., Adey, B. N., Armour, C., Buckman, J. E. J., Coleman, J. R. I., Davies, M. R., Hirsch, C. R., Hotopf, M. H., et al. (2023) · PsyArXiv (OSF Preprints) · doi:10.31234/osf.io/4d6ju · Cited by 1
Barlati, S., Bulgari, V., Calzavara‐Pinton, I., Nibbio, G., Bertoni, L., Zardini, D., Zucchetti, A., Baglioni, A., Paolini, S., Poddighe, L., et al. (2025) · Journal of Mental Health · doi:10.1080/09638237.2025.2512305 · Cited by 1
“…and insomnia (Cui, 2015; Pandi-Perumal et al., 2020), reduced Quality of Life (QoL; Lenox-Smith et al., 2013), cognitive impairments (Barlati et al., 2022; Kriesche et al., 2023), poor ability to perform daily life activities as well as poor social skills (IsHak et al., 2016; Kennedy et al., 2007).”
Watanabe, K., Sumiyoshi, T., Kato, M., Kikuchi, T., Moriguchi, Y., Åström, D. O., & Christensen, M. C. (2025) · Journal of Affective Disorders Reports · doi:10.1016/j.jadr.2025.100955
Christensen, M. C., Ren, H., & Fagiolini, A. (2022) · Figshare · doi:10.6084/m9.figshare.20106649
Christensen, M. C., Ren, H., & Fagiolini, A. (2022) · Figshare · doi:10.6084/m9.figshare.19518603
Wang, M., Qi, X., Yang, X., Fan, H., Dou, Y., Guo, W., Wang, Q., Chen, E., Li, T., & Ma, X. (2022) · Figshare · doi:10.6084/m9.figshare.20423771
Papalexi, E., Galanopoulos, A., Kontis, D., Markopoulou, M., Balta, G., Karavelas, E., Panagiotidis, P., Vlachos, T., & Ettrup, A. (2022) · Figshare · doi:10.6084/m9.figshare.20484658
Luo, R., Fan, N., Dou, Y., Wang, Y., Wang, M., Yang, X., & Ma, X. (2024) · Figshare · doi:10.6084/m9.figshare.25687544
Volovic-Shushan, S., Josman, N., Nov, Y., Nitzan, U., & Adi, S. (2026) · Psychiatry Research · doi:10.1016/j.psychres.2026.117041 · Cited by 1
Introduction to Disability Care in Major Depressive Disorder
Kumar, A., Israr, J., & Alam, S. (2026) · SpringerBriefs in modern perspectives on disability research. · doi:10.1007/978-981-95-8955-5_1
Kodancha, P., Kashyap, H., & Desai, G. (2026) · medRxiv · doi:10.64898/2026.08.12.26360264
Metadata
- Authors
- IsHak, W. W., James, D. M., Mirocha, J., Youssef, H., Tobia, G., Pi, S., Collison, K. L., & Cohen, R. M.
- Affiliations
- Cedars-Sinai Medical Center (US)
- Emory University (US)
- Corresponding author
- IsHak, Waguih William
- Venue
- Therapeutic Advances in Chronic Disease
- Publisher
- SAGE Publications
- Published
- 2016-03-31
- Volume
- 7
- Issue
- 3
- Pages
- 160-169
- ISSN
- 2040-6223 (ISSN-L)
- 2040-6231
- PMC
- PMC4907070
- OpenAlex
- W2327666782
- Cited by
- 71
- References
- 53
- Citations by year
- 2026: 3 · 2025: 9 · 2024: 9 · 2023: 5 · 2022: 21 · 2021: 7 · 2020: 6 · 2019: 6 · 2018: 1 · 2017: 4
- FWCI
- 2.97
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Therapeutic Advances in Chronic Disease (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- McKnight Foundation
- National Institutes of Health (n01mh90003-26-0-0)
- National Institute of Mental Health (N01 MH090003)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- major depressive disorder, functional outcome, antidepressant treatment, STAR*D trial, Work and Social Adjustment Scale, remission, treatment response, social functioning, work functioning, long-term follow-up
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.